ROE (Return on Equity) in Pharmaceuticals & Healthcare
How to interpret and apply roe (return on equity) specifically when analyzing pharmaceuticals & healthcare stocks in India.
Quick Recap: What is ROE (Return on Equity)?
ROE measures how effectively a company uses shareholders' equity to generate profits — the ultimate test of whether management is creating value for owners.
ROE = Net Income ÷ Shareholders' Equity × 100
How ROE (Return on Equity) Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
Typical ROE12-22%
General benchmark: Above 15% is good, above 20% is excellent. Compare within sector.
Example Pharmaceuticals & Healthcare Companies to Analyze
Use the Equiscale Screener → to filter pharmaceuticals & healthcare stocks by roe and other metrics.
Key Takeaways
- ROE (Return on Equity) in pharmaceuticals & healthcare should be compared against sector peers, not the market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Always cross-check with other metrics. No single ratio tells the full story.